Analysts have forecast that this sum could halve by 2017 as generic competitors gain ground.

Those companies will lose a large share of their revenues as a result of lower-priced products from generic competitors.

By paying a settlement that keeps its generic competitors out of the market, the patentee can set a price that's above the market level with its monopoly.